P1125: CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY AND SAFETY OF MOSUNETUZUMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY... por L. Nastoupil, F. Morschhauser, C. W. Scholz, M. Bishton, S.-S. Yoon, P. Giri, M. C. Wei, A. Knapp, C.-C. Li, A. Bottos, H. Li, E. Purev, N. L. Bartlett

Obter o texto integral

P1124: MOSUNETUZUMAB RETREATMENT IS EFFECTIVE AND WELL-TOLERATED IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA por C. Y. Cheah, N. L. Bartlett, S. Assouline, S. J. Schuster, W. Seog Kim, M. Shadman, I. Isufi, S. Yin, M. Y. Doral, J. Sit, V. Chen, H. Huang, M. Zhou, M. C. Wei, L. E. Budde

Obter o texto integral

P1126: MOSUNETUZUMAB IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS AGED <65 AND ≥65 YEARS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: SUBGROUP ANALYSIS OF... por M. Matasar, N. L. Bartlett, L. H. Sehn, S. J. Schuster, S. Assouline, P. Giri, J. Kuruvilla, M. Canales, S. Dietrich, K. Fay, M. Ku, L. J. Nastoupil, M. C. Wei, S. Yin, I. To, D. Turner, H. Huang, J. Min, E. Penuel, L. E. Budde

Obter o texto integral